{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:48:01Z","timestamp":1792838881581,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["Grant No. U-01 58369"],"award-info":[{"award-number":["Grant No. U-01 58369"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s10620-022-07524-6","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T18:04:15Z","timestamp":1652292255000},"page":"304-311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Role of Hepatitis C Infection in Acute Liver Injury\/Acute Liver Failure in North America"],"prefix":"10.1007","volume":"68","author":[{"given":"Ashwin","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody A.","family":"Rule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Cerro-Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Stravitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan M.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2783-5441","authenticated-orcid":false,"given":"William M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"key":"7524_CR1","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/hep.20703","volume":"41","author":"J Polson","year":"2005","unstructured":"Polson J, Lee WM. American Association for the Study of Liver D. AASLD position paper: the management of acute liver failure. Hepatology 2005;41:1179\u20131197.","journal-title":"Hepatology"},{"key":"7524_CR2","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1111\/j.1572-0241.2007.01388.x","volume":"102","author":"WA Bower","year":"2007","unstructured":"Bower WA, Johns M, Margolis HS et al. Population-based surveillance for acute liver failure. Am J Gastroenterol 2007;102:2459\u20132463.","journal-title":"Am J Gastroenterol"},{"key":"7524_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jhep.2012.03.017","volume":"57","author":"G Germani","year":"2012","unstructured":"Germani G, Theocharidou E, Adam R et al. Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol 2012;57:288\u2013296.","journal-title":"J Hepatol"},{"key":"7524_CR4","doi-asserted-by":"publisher","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","volume":"137","author":"G Ostapowicz","year":"2002","unstructured":"Ostapowicz G, Fontana RJ, Schiodt FV et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947\u2013954.","journal-title":"Ann Intern Med"},{"key":"7524_CR5","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/hep.510230622","volume":"23","author":"SK Acharya","year":"1996","unstructured":"Acharya SK, Dasarathy S, Kumer TL et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology 1996;23:1448\u20131455.","journal-title":"Hepatology"},{"issue":"Suppl 3","key":"7524_CR6","doi-asserted-by":"publisher","first-page":"S268","DOI":"10.1046\/j.1440-1746.17.s3.12.x","volume":"17","author":"SK Acharya","year":"2002","unstructured":"Acharya SK, Batra Y, Hazari S et al. Etiopathogenesis of acute hepatic failure: Eastern versus Western countries. J Gastroenterol Hepatol 2002;17:S268\u2013S273.","journal-title":"J Gastroenterol Hepatol"},{"key":"7524_CR7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0140-6736(10)60274-7","volume":"376","author":"W Bernal","year":"2010","unstructured":"Bernal W, Auzinger G, Dhawan A et al. Acute liver failure. Lancet 2010;376:190\u2013201.","journal-title":"Lancet"},{"key":"7524_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0016-5085(89)90081-4","volume":"97","author":"JG O'Grady","year":"1989","unstructured":"O\u2019Grady JG, Alexander GJ, Hayllar KM et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439\u2013445.","journal-title":"Gastroenterology"},{"key":"7524_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJM199608293350904","volume":"335","author":"P Farci","year":"1996","unstructured":"Farci P, Alter HJ, Shimoda A et al. Hepatitis C virus-associated fulminant hepatic failure. N Engl J Med 1996;335:631\u2013634.","journal-title":"N Engl J Med"},{"key":"7524_CR10","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12328-014-0454-x","volume":"7","author":"H Kanzaki","year":"2014","unstructured":"Kanzaki H, Takaki A, Yagi T et al. A case of fulminant liver failure associated with hepatitis C virus. Clin J Gastroenterol 2014;7:170\u2013174.","journal-title":"Clin J Gastroenterol"},{"key":"7524_CR11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-0043-120925","volume":"56","author":"AM Thiel","year":"2018","unstructured":"Thiel AM, Rissland J, Lammert F et al. Acute liver failure as a rare case of a frequent disease. Z Gastroenterol 2018;56:255\u2013258.","journal-title":"Z Gastroenterol"},{"key":"7524_CR12","doi-asserted-by":"crossref","unstructured":"Tracy B, Shrestha R, Stein L, et al. Liver transplantation for fulminant genotype 2a\/c hepatitis C virus marked by a rapid recurrence followed by cure. Transpl Infect Dis 2017;19.","DOI":"10.1111\/tid.12690"},{"key":"7524_CR13","first-page":"1009","volume":"31","author":"BB Younis","year":"2015","unstructured":"Younis BB, Arshad R, Khurhsid S et al. Fulminant hepatic failure (FHF) due to acute hepatitis C. Pak J Med Sci 2015;31:1009\u20131011.","journal-title":"Pak J Med Sci"},{"key":"7524_CR14","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1128\/AAC.49.9.3986-3987.2005","volume":"49","author":"ML Yu","year":"2005","unstructured":"Yu ML, Hou NJ, Dai CY et al. Successful treatment of fulminant hepatitis C by therapy with alpha interferon and ribavirin. Antimicrob Agents Chemother 2005;49:3986\u20133987.","journal-title":"Antimicrob Agents Chemother"},{"key":"7524_CR15","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/ajg.2017.98","volume":"112","author":"DG Koch","year":"2017","unstructured":"Koch DG, Speiser JL, Durkalski V et al. The natural history of severe acute liver injury. Am J Gastroenterol 2017;112:1389\u20131396.","journal-title":"Am J Gastroenterol"},{"key":"7524_CR16","first-page":"213","volume":"8","author":"S Brillanti","year":"1993","unstructured":"Brillanti S, Masci C, Miglioli M et al. Serum IgM antibodies to hepatitis C virus in acute and chronic hepatitis C. Arch Virol Suppl 1993;8:213\u2013218.","journal-title":"Arch Virol Suppl"},{"key":"7524_CR17","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/hep.31060","volume":"71","author":"MG Ghany","year":"2020","unstructured":"Ghany MG, Morgan TR. Panel A-IHCG. Hepatitis C guidance 2019 update: American Association for the study of liver diseases-infectious diseases society of america recommendations for testing, managing, and treating hepatitis C virus infection. Hepatology 2020;71:686\u2013721.","journal-title":"Hepatology"},{"key":"7524_CR18","first-page":"362","volume":"62","author":"Centers for Disease C","year":"2013","unstructured":"Centers for Disease C. Prevention Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb Mortal Wkly Rep 2013;62:362\u2013365.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"7524_CR19","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1086\/428578","volume":"40","author":"AL Cox","year":"2005","unstructured":"Cox AL, Netski DM, Mosbruger T et al. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis 2005;40:951\u2013958.","journal-title":"Clin Infect Dis"},{"key":"7524_CR20","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/j.1537-2995.2005.04390.x","volume":"45","author":"SA Glynn","year":"2005","unstructured":"Glynn SA, Wright DJ, Kleinman SH et al. Dynamics of viremia in early hepatitis C virus infection. Transfusion 2005;45:994\u20131002.","journal-title":"Transfusion"},{"key":"7524_CR21","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/hep.24060","volume":"53","author":"N Khandelwal","year":"2011","unstructured":"Khandelwal N, James LP, Sanders C, Larson AM, Lee WM. Acute Liver Failure Study Group. Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure. Hepatology 2011;53:567\u2013576.","journal-title":"Hepatology"},{"key":"7524_CR22","doi-asserted-by":"publisher","first-page":"15273","DOI":"10.1038\/s41598-018-33419-6","volume":"8","author":"R Fan","year":"2018","unstructured":"Fan R, Wang J, Du J. Association between body mass index and fatty liver risk: a dose-response analysis. Sci Rep 2018;8:15273.","journal-title":"Sci Rep"},{"key":"7524_CR23","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1210\/jc.2015-3444","volume":"101","author":"AK Loomis","year":"2016","unstructured":"Loomis AK, Kabadi S, Preiss D et al. Body mass index and risk of nonalcoholic fatty liver disease: two electronic health record prospective studies. J Clin Endocrinol Metab 2016;101:945\u2013952.","journal-title":"J Clin Endocrinol Metab"},{"key":"7524_CR24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/jgh.12377","volume":"29","author":"T Saida","year":"2014","unstructured":"Saida T, Fukushima W, Ohfuji S et al. Effect modification of body mass index and body fat percentage on fatty liver disease in a Japanese population. J Gastroenterol Hepatol 2014;29:128\u2013136.","journal-title":"J Gastroenterol Hepatol"},{"key":"7524_CR25","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1007\/s11695-015-1696-5","volume":"25","author":"S Morita","year":"2015","unstructured":"Morita S, Neto Dde S, Morita FH et al. Prevalence of non-alcoholic fatty liver disease and steatohepatitis risk factors in patients undergoing bariatric surgery. Obes Surg 2015;25:2335\u20132343.","journal-title":"Obes Surg"},{"key":"7524_CR26","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/jmv.1055","volume":"64","author":"T Kato","year":"2001","unstructured":"Kato T, Furusaka A, Miyamoto M et al. Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient. J Med Virol 2001;64:334\u2013339.","journal-title":"J Med Virol"},{"key":"7524_CR27","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/hep.22422","volume":"48","author":"T Kato","year":"2008","unstructured":"Kato T, Choi Y, Elmowalid G et al. Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation. Hepatology 2008;48:732\u2013740.","journal-title":"Hepatology"},{"key":"7524_CR28","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1365-2036.2010.04549.x","volume":"33","author":"R Loomba","year":"2011","unstructured":"Loomba R, Rivera MM, McBurney R et al. The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes. Aliment Pharmacol Ther 2011;33:559\u2013565.","journal-title":"Aliment Pharmacol Ther"},{"key":"7524_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(08)61116-2","volume":"372","author":"A Maheshwari","year":"2008","unstructured":"Maheshwari A, Ray S, Thuluvath PJ. Acute hepatitis C. Lancet 2008;372:321\u2013332.","journal-title":"Lancet"},{"key":"7524_CR30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0016-5085(03)00668-1","volume":"125","author":"JT Gerlach","year":"2003","unstructured":"Gerlach JT, Diepolder HM, Zachoval R et al. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 2003;125:80\u201388.","journal-title":"Gastroenterology"},{"key":"7524_CR31","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.jmb.2013.10.032","volume":"426","author":"SM Horner","year":"2014","unstructured":"Horner SM. Activation and evasion of antiviral innate immunity by hepatitis C virus. J Mol Biol 2014;426:1198\u20131209.","journal-title":"J Mol Biol"},{"key":"7524_CR32","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1128\/JVI.00174-13","volume":"87","author":"H Kim","year":"2013","unstructured":"Kim H, Meyer K, Di Bisceglie AM et al. Hepatitis C virus suppresses C9 complement synthesis and impairs membrane attack complex function. J Virol 2013;87:5858\u20135867.","journal-title":"J Virol"},{"key":"7524_CR33","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1128\/JVI.06577-11","volume":"86","author":"B Mazumdar","year":"2012","unstructured":"Mazumdar B, Kim H, Meyer K et al. Hepatitis C virus proteins inhibit C3 complement production. J Virol 2012;86:2221\u20132228.","journal-title":"J Virol"},{"key":"7524_CR34","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1128\/JVI.02449-10","volume":"85","author":"A Banerjee","year":"2011","unstructured":"Banerjee A, Mazumdar B, Meyer K et al. Transcriptional repression of C4 complement by hepatitis C virus proteins. J Virol 2011;85:4157\u20134166.","journal-title":"J Virol"},{"key":"7524_CR35","first-page":"977","volume":"13","author":"YC Kwon","year":"2014","unstructured":"Kwon YC, Ray RB, Ray R. Hepatitis C virus infection: establishment of chronicity and liver disease progression. EXCLI J 2014;13:977\u2013996.","journal-title":"EXCLI J"},{"key":"7524_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.psychres.2016.04.114","volume":"243","author":"A Dantas-Duarte","year":"2016","unstructured":"Dantas-Duarte A, Morais-de-Jesus M, Nunes AP et al. Risk-taking behavior and impulsivity among HCV-infected patients. Psychiatry Res. 2016;243:75\u201380. https:\/\/doi.org\/10.1016\/j.psychres.2016.04.114.","journal-title":"Psychiatry Res."},{"key":"7524_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jpsychores.2017.08.006","volume":"101","author":"C Pezzia","year":"2017","unstructured":"Pezzia C, Sanders C, Welch S, Bowling A, Lee WM. Acute Liver Failure Study Group. Psychosocial and behavioral factors in acetaminophen-related acute liver failure and liver injury. J Psychosom Res. 2017;101:51\u201357. https:\/\/doi.org\/10.1016\/j.jpsychores.2017.08.006.","journal-title":"J Psychosom Res."},{"issue":"4","key":"7524_CR38","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/hep.22536","volume":"48","author":"GC Nguyen","year":"2008","unstructured":"Nguyen GC, Sam J, Thuluvath PJ. Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis. Hepatology. 2008;48:1336\u20131341. https:\/\/doi.org\/10.1002\/hep.22536.","journal-title":"Hepatology."},{"key":"7524_CR39","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1136\/jcp.50.5.401","volume":"50","author":"V Paradis","year":"1997","unstructured":"Paradis V, Mathurin P, Kollinger M, Imbert-Bismut F, Charlotte F, Piton A et al. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J Clin Pathol 1997;50:401\u2013406.","journal-title":"J Clin Pathol"},{"key":"7524_CR40","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/S0891-5849(97)00437-1","volume":"24","author":"E Larrea","year":"1998","unstructured":"Larrea E, Beloqui O, Munoz-Navas MA, Civeira MP, Prieto J. Superoxide dismutase in patients with chronic hepatitis C virus infection. Free Radic Biol Med 1998;24:1235\u20131241.","journal-title":"Free Radic Biol Med"},{"key":"7524_CR41","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S0168-8278(99)80128-7","volume":"30","author":"G Barbaro","year":"1999","unstructured":"Barbaro G, Di LG, Ribersani M, Soldini M, Giancaspro G, Bellomo G et al. Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype. J Hepatol 1999;30:774\u2013782.","journal-title":"J Hepatol"},{"key":"7524_CR42","doi-asserted-by":"publisher","first-page":"6326","DOI":"10.1182\/blood-2011-12-393637","volume":"119","author":"MP Busch","year":"2012","unstructured":"Busch MP, Murthy KK, Kleinman SH et al. Infectivity in chimpanzees (Pan troglodytes) of plasma collected before HCV RNA detectability by FDA-licensed assays: implications for transfusion safety and HCV infection outcomes. Blood 2012;119:6326\u20136334.","journal-title":"Blood"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07524-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-022-07524-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07524-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:37:29Z","timestamp":1744202249000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-022-07524-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["7524"],"URL":"https:\/\/doi.org\/10.1007\/s10620-022-07524-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"assertion":[{"value":"22 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"WML serves as a consultant for Affibody, Genentech, Forma, Karuna, SeaGen, Cortexyme, Pfizer, and Alnylam. He receives research funding to conduct clinical trials from Merck, BMS, Intercept, Novo Nordisk, Eiger, and Alexion. RJF receives research support from AbbVie, Gilead, and Bristol Myers Squibb and has consulted for Sanofi. RTS receives funding from IL and Exalenz. AR, JR, GC, BMM, and GL have no financial disclosures to report. All authors certify that they have no non-financial interests (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}